TRIESENCE DIN 02368676
Status: Marketed
Holder: NOVARTIS PHARMACEUTICALS CANADA INC
Molecule: TRIAMCINOLONE ACETONIDE
Available to quote
Health Canada record
| Active ingredient(s) | TRIAMCINOLONE ACETONIDE 40 MG |
|---|---|
| Dosage form | Suspension |
| Route | Intravitreal |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | S01BA05 TRIAMCINOLONE |
| Original market date | 22-Aug-2012 |
| Current status date | 12-Nov-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Novartis Pharmaceuticals Canada Inc — licence 100273, currently licensed, last inspection rating C (2025-01-14).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TRIAMCINOLONE ACETONIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02437635 | APO-TRIAMCINOLONE AQ | APOTEX INC | Spray (Metered-Dose) | TRIAMCINOLONE ACETONIDE 55 MCG | Marketed |
| 02194066 | ARISTOCORT C | BAUSCH HEALTH, CANADA INC. | Cream | TRIAMCINOLONE ACETONIDE 0.5 % | Marketed |
| 02194031 | ARISTOCORT R | BAUSCH HEALTH, CANADA INC. | Ointment | TRIAMCINOLONE ACETONIDE 0.1 % | Marketed |
| 02194058 | ARISTOCORT R | BAUSCH HEALTH, CANADA INC. | Cream | TRIAMCINOLONE ACETONIDE 0.1 % | Marketed |
| 01999761 | KENALOG-10 INJECTION | BRISTOL-MYERS SQUIBB CANADA | Suspension | TRIAMCINOLONE ACETONIDE 10 MG | Marketed |
| 01999869 | KENALOG-40 INJECTION | BRISTOL-MYERS SQUIBB CANADA | Suspension | TRIAMCINOLONE ACETONIDE 40 MG | Marketed |
| 02417510 | NASACORT ALLERGY 24HR | SANOFI CONSUMER HEALTH INC | Spray (Metered-Dose) | TRIAMCINOLONE ACETONIDE 55 MCG | Marketed |
| 02213834 | NASACORT AQ | SANOFI CONSUMER HEALTH INC | Spray (Metered-Dose) | TRIAMCINOLONE ACETONIDE 55 MCG | Marketed |
| 02451735 | NASAL SPRAY ALLERGY 24HR | APOTEX INC | Spray (Metered-Dose) | TRIAMCINOLONE ACETONIDE 55 MCG | Approved |
| 01964054 | ORACORT | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. | Paste | TRIAMCINOLONE ACETONIDE 0.1 % | Marketed |
| 00550507 | TEVA-TRIACOMB | TEVA CANADA LIMITED | Cream | TRIAMCINOLONE ACETONIDE 1 MG; NYSTATIN 100000 UNIT; NEOMYCIN (NEOMYCIN SULFATE) 2.5 MG; GRAMICIDIN 0.25 MG | Marketed |
| 02022818 | THERADERM CREAM | BIMEDA-MTC ANIMAL HEALTH INC | Cream | TRIAMCINOLONE ACETONIDE 1 MG; NYSTATIN 100000 UNIT; NEOMYCIN (NEOMYCIN SULFATE) 2.5 MG; GRAMICIDIN 0.25 MG | Marketed |
| 00716960 | TRIADERM CRM 0.1% | TARO PHARMACEUTICALS INC | Cream | TRIAMCINOLONE ACETONIDE 0.1 % | Marketed |
| 01977563 | TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION USP | STERIMAX INC | Suspension | TRIAMCINOLONE ACETONIDE 40 MG | Marketed |
| 00717002 | VIADERM KC CRM | TARO PHARMACEUTICALS INC | Cream | TRIAMCINOLONE ACETONIDE 1 MG; NEOMYCIN (NEOMYCIN SULFATE) 2.5 MG; GRAMICIDIN 0.25 MG; NYSTATIN 100000 UNIT | Marketed |
| 00717029 | VIADERM KC ONT | TARO PHARMACEUTICALS INC | Ointment | TRIAMCINOLONE ACETONIDE 1 MG; NEOMYCIN (NEOMYCIN SULFATE) 2.5 MG; GRAMICIDIN 0.25 MG; NYSTATIN 100000 UNIT | Marketed |
| 02559358 | XIPERE | BAUSCH & LOMB INC | Suspension | TRIAMCINOLONE ACETONIDE 40 MG | Approved |
| 00014648 | ARISTOCORT C CRM 0.5% | LEDERLE CYANAMID CANADA INC. | Cream | TRIAMCINOLONE ACETONIDE 5 MG | Cancelled Post Market |
| 00014621 | ARISTOCORT R CRM 0.1% | LEDERLE CYANAMID CANADA INC. | Cream | TRIAMCINOLONE ACETONIDE 1 MG | Cancelled Post Market |
| 00128058 | ARISTOFORM R CRM 0.1% | LEDERLE CYANAMID CANADA INC. | Cream | TRIAMCINOLONE ACETONIDE 1 MG; CLIOQUINOL 30 MG | Cancelled Post Market |
| 01926314 | AZMACORT | AVENTIS PHARMA INC | Metered-Dose Aerosol | TRIAMCINOLONE ACETONIDE 200 MCG | Cancelled Post Market |
| 01999850 | KENACOMB CREAM | WESTWOOD-SQUIBB, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Cream | TRIAMCINOLONE ACETONIDE 1 MG; NEOMYCIN SULFATE 2.5 MG; GRAMICIDIN .25 MG; NYSTATIN 100000 UNIT | Cancelled Post Market |
| 01999826 | KENACOMB OINTMENT | WESTWOOD-SQUIBB, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Ointment | TRIAMCINOLONE ACETONIDE 1 MG; NEOMYCIN SULFATE 2.5 MG; GRAMICIDIN .25 MG; NYSTATIN 100000 UNIT | Cancelled Post Market |
| 00245267 | KENACOMB ONT | SQUIBB CANADA INC., DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Ointment | TRIAMCINOLONE ACETONIDE 1 MG; NEOMYCIN (NEOMYCIN SULFATE) 2.5 MG; GRAMICIDIN .25 MG; NYSTATIN 100000 UNIT | Cancelled Post Market |
| 01999818 | KENALOG CREAM 0.1% | WESTWOOD-SQUIBB, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Cream | TRIAMCINOLONE ACETONIDE 1 MG | Cancelled Post Market |
| 01999788 | KENALOG IN ORABASE 0.1% | BRISTOL-MYERS SQUIBB CANADA | Paste | TRIAMCINOLONE ACETONIDE 1 MG | Cancelled Post Market |
| 01999796 | KENALOG OINTMENT 0.1% | WESTWOOD-SQUIBB, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Ointment | TRIAMCINOLONE ACETONIDE 1 MG | Cancelled Post Market |
| 00029572 | KENALOG ONT 0.1% | SQUIBB CANADA INC., DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Ointment | TRIAMCINOLONE ACETONIDE 1 MG | Cancelled Post Market |
| 00464554 | MECOMB CRM 0.1% | MEDIC LABORATORY LTÉE | Cream | TRIAMCINOLONE ACETONIDE 1 MG; NEOMYCIN (NEOMYCIN SULFATE) 2.5 MG; GRAMICIDIN .25 MG; NYSTATIN 100000 UNIT | Cancelled Post Market |
| 01913328 | NASACORT | SANOFI-AVENTIS CANADA INC | Metered-Dose Aerosol | TRIAMCINOLONE ACETONIDE 100 MCG | Cancelled Post Market |
| 02080478 | ORIBIOTIC | BIMEDA-MTC ANIMAL HEALTH INC | Ointment | TRIAMCINOLONE ACETONIDE 0.86 MG; NEOMYCIN (NEOMYCIN SULFATE) 3 MG; NYSTATIN 86000 UNIT; BACITRACIN 430 UNIT; LIDOCAINE 8.6 MG | Dormant |
| 02219271 | SCHEINPHARM TRIAMCINE-A INJECT.SUS-40MG/ML | SCHEIN PHARMACEUTICAL CANADA INC. | Suspension | TRIAMCINOLONE ACETONIDE 40 MG | Cancelled Post Market |
| 00716979 | TRIADERM ONT 0.025% | TARO PHARMACEUTICALS INC | Ointment | TRIAMCINOLONE ACETONIDE 0.25 MG | Cancelled Post Market |
| 00716987 | TRIADERM ONT 0.1% | TARO PHARMACEUTICALS INC | Ointment | TRIAMCINOLONE ACETONIDE 0.1 % | Cancelled Post Market |
| 02229550 | TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION USP | SANDOZ CANADA INCORPORATED | Suspension | TRIAMCINOLONE ACETONIDE 40 MG | Cancelled Post Market |
| 02229540 | TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION USP | SANDOZ CANADA INCORPORATED | Suspension | TRIAMCINOLONE ACETONIDE 10 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 18932 | 2017-02-03 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBER |
| 12425 | 2011-06-14 | New Drug Submission (NDS) |
International API supply for TRIAMCINOLONE ACETONIDE
5 valid EDQM Certificates of Suitability from 5 holders. 14 active FDA Drug Master Files.
Request a quote for TRIESENCE